建议使用-埃皮-安德罗 (BEA) 治疗刚性人群综合征 (SPS)
1McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, WI 53705, USA.
Microorganisms
|April 26, 2025
概括
刚性人体综合征 (SPS) 可能是由Mycobacterium avium亚种的帕拉结核病 (MAP) 感染引发的,导致抗谷氨酸脱酶 (GAD) 抗体. -epi-androsterone (BEA) 由于其免疫调节和抗菌素作用,对治疗SPS有很大的希望.
科学领域:
- 神经免疫学 神经免疫学
- 传染病免疫学 传染病免疫学
- 内分泌学 在内分泌学.
背景情况:
- 刚性人综合征 (SPS) 是一种罕见的自身免疫性疾病,其特征是逐渐肌肉硬和.
- SPS的一个关键特征是存在抗谷氨酸脱酶 (GAD) 的抗体,这种酶对于产生抑制性神经递质胺黄油酸 (GABA) 至关重要.
- 中央神经系统的GABAergic活性降低导致神经元过度兴奋,表现为SPS的特征性刚性和.
研究的目的:
- 提出Mycobacterium avium亚种结核病 (MAP) 作为SPS的潜在传染性触发物.
- 探索-epi-androsterone (BEA) 在SPS管理中的潜在治疗作用.
主要方法:
- 对SPS,GAD抗体,1型糖尿病 (T1D),真菌细菌感染和类固醇代谢组的现有研究进行审查.
- 对GAD和菌根热冲击蛋白65 (mHSP65) 之间的分子相似性的分析.
- 评估BEA的特性,包括其免疫调节和抗菌素活性.
主要成果:
- 在SPS和T1D中常见的抗GAD抗体与mHSP65有关,mHSP65是对MAP感染的反应.
- 在GAD和mHSP65表位之间存在结构上的相似之处,这表明分子模仿.
- BEA是一种合成的DHEA模拟物,非雄激素,调节免疫失调,并表现出抗菌菌作用.
结论:
- MAP感染是SPS的一个可信的传染性触发器,由抗GAD抗体介导.
- 作为免疫稳定剂和抗感染剂的BEA的双重作用表明它在SPS治疗中的潜在有效性.
- 通过随机临床试验对BEA进行进一步的研究是有必要的,以评估其对SPS患者的治疗益处.
相关概念视频
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
2.4K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.4K
01:30Adrenergic Agonists: Therapeutic Uses
675
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
675
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
99
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
99
01:28Adrenergic Agonists: Mixed-Action Agents
617
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
617
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
85
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
85
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
86
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
86